(Q28252883)

0 references

Larry R Ellingsworth

0 references

Sarah A Frech

0 references

David M Frerichs

0 references

Robert C Seid

0 references

Jianmei Yu

Expert Review of Vaccines

0 references

language of work or name

English

0 references

publication date

October 2007

0 references

published in

0 references

volume

0 references

issue

0 references

page(s)

809-19

0 references

cites work

Nonclinical safety evaluation of Escherichia coli heat-labile toxin mucosal adjuvant as a component of a nasal influenza vaccine

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Mutant Escherichia coli heat-labile toxin B subunit that separates toxoid-mediated signaling and immunomodulatory action from trafficking and delivery functions

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Immunostimulant patch containing heat-labile enterotoxin from Escherichia coli enhances immune responses to injected influenza virus vaccine through activation of skin dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Gangliosides are receptors for murine polyoma virus and SV40

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

GM1 binding-deficient exotoxin is a potent noninflammatory broad spectrum intradermal immunoadjuvant

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Mutants of the Escherichia coli heat-labile enterotoxin as safe and strong adjuvants for intranasal delivery of vaccines

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Immunostimulant patch enhances immune responses to influenza virus vaccine in aged mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization induces mucosal CTLs and protective immunity by migration of primed skin dendritic cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization with Clostridium difficile toxoid A induces systemic and mucosal immune responses and toxin A-neutralizing antibodies in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Induction of protective immunity against lethal anthrax challenge with a patch

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization with the heat-labile toxin (LT) of enterotoxigenic Escherichia coli (ETEC): protective efficacy in a double-blind, placebo-controlled challenge study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization using colonization factor and heat-labile enterotoxin induces correlates of protective immunity for enterotoxigenic Escherichia coli

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Regulation of intestinal immunity: effects of the oral adjuvant Escherichia coli heat-labile enterotoxin on migrating dendritic cells.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Mucosal immunization with HIV-1 peptide vaccine induces mucosal and systemic cytotoxic T lymphocytes and protective immunity in mice against intrarectal recombinant HIV-vaccinia challenge

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

In vivo estimation of stratum corneum thickness from water concentration profiles obtained with Raman spectroscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

The Validity and Practicality of Sun-Reactive Skin Types I Through VI

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Topographic variations in normal skin, as viewed by in vivo reflectance confocal microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Epidermal thickness, skin pigmentation and constitutive photosensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Morphological and quantitative analyses of normal epidermal Langerhans cells using confocal scanning laser microscopy

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Safety and immunogenicity of a prototype enterotoxigenic Escherichia coli vaccine administered transcutaneously

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Safety and immunogenicity of an enterotoxigenic Escherichia coli vaccine patch containing heat-labile toxin: use of skin pretreatment to disrupt the stratum corneum

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization with bacterial ADP-ribosylating exotoxins, subunits, and unrelated adjuvants

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Parenteral adjuvant activities of Escherichia coli heat-labile toxin and its B subunit for immunization of mice against gastric Helicobacter pylori infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Percutaneous peptide immunization via corneum barrier-disrupted murine skin for experimental tumor immunoprophylaxis

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization with cytotoxic T-cell peptide epitopes provides effective antitumor immunity in mice

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Epicutaneous application of CpG oligodeoxynucleotides with peptide or protein antigen promotes the generation of CTL.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Cutting edge: priming of CTL by transcutaneous peptide immunization with imiquimod

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Phase I evaluation of intranasal trivalent inactivated influenza vaccine with nontoxigenic Escherichia coli enterotoxin and novel biovector as mucosal adjuvants, using adult volunteers

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Safety and immunogenicity of oral inactivated whole-cell Helicobacter pylori vaccine with adjuvant among volunteers with or without subclinical infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization of domestic animals: opportunities and challenges

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Transcutaneous immunization with inactivated influenza virus induces protective immune responses

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Safety and immunogenicity of an inactivated subvirion influenza A (H5N1) vaccine.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Vaccination against enterotoxigenic Escherichia coli, a cause of travelers' diarrhea

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809

Skin immunization made possible by cholera toxin

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14760584.6.5.809